Advanced Cancer Therapeutics

about advanced cancer therapeutics

Advanced Cancer Therapeutics (ACT) is leading innovation within the biotechnology industry. Founded in January 2007, the company is focused on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. Utilizing its groundbreaking business arrangement with the James Graham Brown Cancer Center and the University of Louisville Research Foundation, ACT will establish exclusive rights to specific novel therapeutics and fast-track these leading edge discoveries to the pharmaceutical industry, and ultimately the patients who need them.

recent news

U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-cancer Product Portfolio April 3, 2012 click here

Dr. Gilles Tapolsky, Chief Scientific Officer, will present at the annual World Cancer Metabolism Summit February 1 - 2, 2012 in Washington, D.C. Presentation will be on ACT’s novel cancer metabolism programs. January 30, 2012 click here

Randall Riggs, President & CEO, has been selected to present at the MidAmerican Healthcare Venture Form, November 8-9, 2011 in Louisville, KY. October 19, 2011 click here

Advanced Cancer Therapeutics to Acquire Antisoma Drug May 3, 2011 click here